LifePoint Health Company Profile (NASDAQ:LPNT)

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

LifePoint Health, Inc. (NASDAQ:LPNT) issued its quarterly earnings results on Tuesday, August, 1st. The company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.06. The firm had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business's revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.69 EPS. View LifePoint Health's Earnings History.

LifePoint Health is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for LifePoint Health.

LifePoint Health issued an update on its FY17 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of $3.92-$4.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.19. The company issued revenue guidance of $6.425-$6.500 billion, compared to the consensus revenue estimate of $6.55 billion.

13 analysts have issued 1 year price targets for LifePoint Health's shares. Their predictions range from $59.00 to $77.00. On average, they expect LifePoint Health's stock price to reach $65.50 in the next twelve months. View Analyst Ratings for LifePoint Health.

Here are some recent quotes from research analysts about LifePoint Health stock:

• 1. According to Zacks Investment Research, "LifePoint Health’s stock has underperformed the industry year to date. Its focus on strategic growth through acquisition and integration of well-positioned hospitals in the growing areas of the U.S. have contributed to its top line growth. The company has also been divesting non-core operations to focus on core growth areas. Its sufficient cash enables the company to make acquisitions and buyback shares. Following second-quarter results, the company trimmed its 2017 guidance on a challenging volume environment and weak revenue growth. The company is faced with increasing expenses which has outpaced revenue growth thereby squeezing operating margins. High bad debt is another concern. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% downward over the last 60 days." (9/11/2017)
• 2. Cantor Fitzgerald analysts commented, "We are reiterating our neutral rating and $55 price target, adjusting our 2017 adjusted EPS estimates and introducing 2018 estimates. Margins continue to be weak, and although we expect them to be relatively stable in 2017-18, our earnings outlook is generally lower than consensus and management's 2017 outlook. In our view, LPNT's acquisition strategy and joint venture have added some promising properties, but they are weighing on earnings as volumes remain disappointing." (2/21/2017)

Some companies that are related to LifePoint Health include HealthSouth Corporation (HLS), Acadia Healthcare Company (ACHC), Mednax (MD), Molina Healthcare (MOH), Chemed Corp. (CHE), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), Tenet Healthcare Corporation (THC), HMS Holdings Corp (HMSY), Community Health Systems (CYH), China Cord Blood Corporation (CO), HealthStream (HSTM), Kindred Healthcare (KND), American Renal Associates Holdings (ARA), Georgia Healthcare Group PLC (GHG), Cambian Group PLC (CMBN), Concord Medical Services Holdings Limited (CCM) and Nobilis Health Corp (HLTH).

LifePoint Health's management team includes the folowing people:

• William F. Carpenter III, Chairman of the Board, Chief Executive Officer
• David M. Dill, President, Chief Operating Officer
• Michael S. Coggin, Chief Financial Officer, Executive Vice President, Chief Accounting Officer
• Victor Giovanetti, President — Eastern Group
• Robert N. Klein, President — Western Group
• R. Scott Raplee, President - Central Group
• Melissa O. Waddey, President - Ambulatory and Operations Services
• John P. Bumpus, Executive Vice President, Chief Administrative Officer
• Jennifer C. Peters, Senior Vice President, General Counsel
• Russell L. Holman M.D., Chief Medical Officer

LifePoint Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.11%), Dimensional Fund Advisors LP (8.44%), American Century Companies Inc. (8.40%), Vanguard Group Inc. (8.25%), LSV Asset Management (4.97%) and Alliancebernstein L.P. (4.29%). Company insiders that own LifePoint Health stock include David M Dill, Gregory T Bier, John E D D S Maupin Jr, John P Bumpus, Richard H Evans and William F Carpenter III. View Institutional Ownership Trends for LifePoint Health.

LifePoint Health's stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., KBC Group NV, Russell Investments Group Ltd., BlackRock Inc., Prudential PLC, Hotchkis & Wiley Capital Management LLC, First Trust Advisors LP and Diamond Hill Capital Management Inc.. Company insiders that have sold LifePoint Health stock in the last year include David M Dill, John P Bumpus, Richard H Evans and William F Carpenter III. View Insider Buying and Selling for LifePoint Health.

LifePoint Health's stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, Victory Capital Management Inc., Bank of New York Mellon Corp, Brandywine Global Investment Management LLC, New Amsterdam Partners LLC NY, Prudential Financial Inc., Balyasny Asset Management LLC and WINTON GROUP Ltd. View Insider Buying and Selling for LifePoint Health.

Shares of LifePoint Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of LifePoint Health stock can currently be purchased for approximately $57.20.